NCT03669614 - SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

December 7, 2018

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions

Cystic Fibrosis

Interventions

DRUG

Inhaled AR-501

single and multiple ascending doses of inhaled AR-501

DRUG

Inhaled Placebo

single and multiple ascending doses of inhaled placebo

Trial Locations (25)

10532

RECRUITING

Research Site, New York

19104

RECRUITING

Research Site, Philadelphia

21204

RECRUITING

Research Site, Baltimore

32610

RECRUITING

Research Site, Gainesville

32803

RECRUITING

Research Site, Orlando

33021

RECRUITING

Research Site, Hollywood

33136

RECRUITING

Research Site, Miami

33606

RECRUITING

Research Site, Tampa

40202

RECRUITING

Research Site, Louisville

43205

RECRUITING

Research Site, Columbus

44106

RECRUITING

Research Site, Cleveland

48201

RECRUITING

Research Site, Detroit

55242

RECRUITING

Research Site, Iowa City

60093

RECRUITING

Research Site, Chicago

66212

COMPLETED

Research Site, Overland Park

68198

RECRUITING

Research Site, Omaha

73104

RECRUITING

Research Site, Oklahoma City

75708

RECRUITING

Research Site, Tyler

80206

RECRUITING

Research Site, Denver

84132

RECRUITING

Research Site, Salt Lake City

85724

RECRUITING

Research Site, Tucson

90806

RECRUITING

Research Site, Long Beach

98195

RECRUITING

Research Site, Seattle

99204

RECRUITING

Research Site, Spokane

04102

RECRUITING

Research Site, Portland